<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>biopharma</title>
    <link>https://pitchbook.com/tag/biopharma</link>
    <description>biopharma</description>
    <language>en-US</language>
    <lastBuildDate>Fri, 29 May 2026 22:59:03 GMT</lastBuildDate>
    <atom:link href="https://pitchbook.com/tag/biopharma.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Some investors are turning to biotech as a hedge against potential AI bubbles</title>
      <link>https://pitchbook.com/news/articles/some-investors-are-turning-to-biotech-as-a-hedge-against-potential-ai-bubbles</link>
      <description>They're betting that with the continuous need for health care, the sector is more immune.</description>
      <pubDate>Fri, 29 May 2026 22:59:03 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/some-investors-are-turning-to-biotech-as-a-hedge-against-potential-ai-bubbles</guid>
    </item>
    <item>
      <title>Jeito holds $1.2B close for biopharma fund as industry braces for next patent cliff</title>
      <link>https://pitchbook.com/news/articles/jeito-holds-1-2b-close-for-biopharma-fund-as-industry-braces-for-next-patent-cliff</link>
      <description>Investors are eyeing a strong M&amp;A cycle ahead of 2030.</description>
      <pubDate>Wed, 08 Apr 2026 12:58:01 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/jeito-holds-1-2b-close-for-biopharma-fund-as-industry-braces-for-next-patent-cliff</guid>
    </item>
    <item>
      <title>Linda Yaccarino's GLP-1 telehealth unicorn raises $200M on adherence claim that bucks industry norm</title>
      <link>https://pitchbook.com/news/articles/linda-yaccarinos-glp-1-telehealth-unicorn-raises-200m-on-adherence-claim-that-bucks-industry-norm</link>
      <description>EMed secures Series A at a $2B valuation. But will its adherence rate hold up at scale?</description>
      <pubDate>Fri, 27 Mar 2026 05:10:21 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/linda-yaccarinos-glp-1-telehealth-unicorn-raises-200m-on-adherence-claim-that-bucks-industry-norm</guid>
    </item>
    <item>
      <title>AI biotechs fetch big premiums as investors pile into drug discovery startups</title>
      <link>https://pitchbook.com/news/articles/ai-biotechs-fetch-big-premiums-as-investors-pile-into-drug-discovery-startups</link>
      <description>Founders say they're workshopping their edge over conventional LLMs for drug development purposes.</description>
      <pubDate>Tue, 25 Nov 2025 20:43:45 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/ai-biotechs-fetch-big-premiums-as-investors-pile-into-drug-discovery-startups</guid>
    </item>
    <item>
      <title>Market Map: Investors have chemistry with biopharma</title>
      <link>https://pitchbook.com/news/articles/market-map-investors-chemistry-biopharma</link>
      <description>The chemistry sector of biopharma has consistently been the vertical's best performing segment.</description>
      <pubDate>Fri, 10 Jan 2025 22:04:50 GMT</pubDate>
      <guid>https://pitchbook.com/news/articles/market-map-investors-chemistry-biopharma</guid>
    </item>
  </channel>
</rss>
